Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (AAVXF) Interest Expenses (2024 - 2025)

Historic Interest Expenses for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to -$108.8 million.

  • Abivax's Interest Expenses fell 106890.28% to -$108.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.1 million, marking a year-over-year decrease of 30031.26%. This contributed to the annual value of $18.2 million for FY2024, which is 3978.52% down from last year.
  • Per Abivax's latest filing, its Interest Expenses stood at -$108.8 million for Q3 2025, which was down 106890.28% from -$6.1 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Interest Expenses ranged from a high of $35.9 million in Q4 2024 and a low of -$108.8 million during Q3 2025